Nanomaterials as an advanced nano-tool for the doxorubicin delivery/ Co-Delivery—A comprehensive review

[1]  S. Pandey,et al.  TiO2-based nanocomposites for cancer diagnosis and therapy: A comprehensive review , 2023, Journal of Drug Delivery Science and Technology.

[2]  S. Pandey,et al.  Innovative nanomaterials for cancer diagnosis, imaging, and therapy: Drug deliveryapplications , 2023, Journal of Drug Delivery Science and Technology.

[3]  A. Díez-Pascual,et al.  Chitosan/Gamma-Alumina/Fe3O4@5-FU Nanostructures as Promising Nanocarriers: Physiochemical Characterization and Toxicity Activity , 2022, Molecules.

[4]  G. Yin,et al.  Gene delivery of chitosan-graft-polyethyleneimine vectors loaded on scaffolds for nerve regeneration. , 2022, Carbohydrate polymers.

[5]  Hailong An,et al.  Multi-target tracheloside and doxorubicin combined treatment of lung adenocarcinoma. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  Sudhir Kumar Jain,et al.  Polymeric micelles and cancer therapy: an ingenious multimodal tumor-targeted drug delivery system , 2022, Drug Delivery and Translational Research.

[7]  A. Ivanova,et al.  A doxorubicin-peptide-gold nanoparticle conjugate as a functionalized drug delivery system: exploring the limits. , 2022, Physical chemistry chemical physics : PCCP.

[8]  S. Hussain,et al.  Design and Evaluation of pH Sensitive PEG-Protamine Nanocomplex of Doxorubicin for Treatment of Breast Cancer , 2022, Polymers.

[9]  S. M. Taghdisi,et al.  Targeted biomimetic hollow mesoporous organosilica nanoparticles for delivery of doxorubicin to colon adenocarcinoma: In vitro and in vivo evaluation , 2022, Microporous and Mesoporous Materials.

[10]  Khaled S. Allemailem,et al.  Lipid-Based Nanoparticle Formulation of Diallyl Trisulfide Chemosensitizes the Growth Inhibitory Activity of Doxorubicin in Colorectal Cancer Model: A Novel In Vitro, In Vivo and In Silico Analysis , 2022, Molecules.

[11]  G. Pitarresi,et al.  Development of stimulus-sensitive electrospun membranes based on novel biodegradable segmented polyurethane as triggered delivery system for doxorubicin. , 2022, Biomaterials advances.

[12]  Yuzhuo Wang,et al.  Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance , 2022, Expert opinion on drug delivery.

[13]  M. Sheibani,et al.  Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches , 2022, Cardiovascular Toxicology.

[14]  D. Weissman,et al.  Lipid nanoparticles delivering constitutively active STING mRNA as a novel anti-cancer therapeutic approach , 2022, bioRxiv.

[15]  Liping Sun,et al.  Amplification of anticancer efficacy by co-delivery of doxorubicin and lonidamine with extracellular vesicles , 2022, Drug delivery.

[16]  Chuanglong He,et al.  Tumor cell membrane-camouflaged responsive nanoparticles enable MRI-guided immuno-chemodynamic therapy of orthotopic osteosarcoma , 2022, Bioactive materials.

[17]  T. Anirudhan,et al.  Chitosan-hyaluronic acid-based hydrogel for the pH-responsive Co-delivery of cisplatin and doxorubicin , 2022, International Journal of Biological Macromolecules.

[18]  N. Zarghami,et al.  Stimulus-responsive drug/gene delivery system based on polyethylenimine cyclodextrin nanoparticles for potential cancer therapy. , 2021, Carbohydrate polymers.

[19]  Yahui Wu,et al.  GSH-sensitive polymeric prodrug: Synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine , 2021, Acta pharmaceutica Sinica. B.

[20]  A. Shati,et al.  Co-Delivery of Anticancer Drugs Via Poly(Ionic Crosslinked Chitosan-Palladium) Nanocapsules: Targeting More Effective and Sustainable Cancer Therapy , 2022, SSRN Electronic Journal.

[21]  Xiangrui Liu,et al.  Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer , 2021, Journal of Nanobiotechnology.

[22]  H. Namazi,et al.  Simple fabrication of multifunctional hyperbranched copolymer based on l-lysine and citric acid for co-delivery of anticancer drugs to breast cancer cells , 2021, Reactive and Functional Polymers.

[23]  Michael R Hamblin,et al.  Potential of natural products in osteosarcoma treatment: Focus on molecular mechanisms. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[24]  A. Scarsbrook,et al.  Impact of 18F-fluciclovine PET/CT on salvage radiotherapy plans for men with recurrence of prostate cancer postradical prostatectomy , 2021, Nuclear medicine communications.

[25]  R. Sabouni,et al.  pH and ultrasound dual-responsive drug delivery system based on PEG–folate-functionalized Iron-based metal–organic framework for targeted doxorubicin delivery , 2021 .

[26]  Kuen-Song Lin,et al.  Design of doxorubicin encapsulated pH-/thermo-responsive and cationic shell-crosslinked magnetic drug delivery system. , 2021, Colloids and surfaces. B, Biointerfaces.

[27]  S. Ramakrishna,et al.  Controlled Drug Delivery Systems: Current Status and Future Directions , 2021, Molecules.

[28]  Hengyi Xu,et al.  Poly-l-lysine-functionalized magnetic beads combined with polymerase chain reaction for the detection of Staphylococcus aureus and Escherichia coli O157:H7 in milk. , 2021, Journal of dairy science.

[29]  H. Hashemi,et al.  Understanding the pH dependent fluorescence and doxorubicin release from graphene oxide functionalized citric acid dendrimer as a highly efficient drug delivery system , 2021 .

[30]  Q. Song,et al.  Synergistic Anticancer Effects of Cisplatin Combined with Combretastatin A4 Phosphate on Human Osteosarcoma-Xenografted Mice , 2021, Cells Tissues Organs.

[31]  Joo-Youp Lee,et al.  Calcium phosphate-polymeric nanoparticle system for co-delivery of microRNA-21 inhibitor and doxorubicin. , 2021, Colloids and surfaces. B, Biointerfaces.

[32]  F. Ungaro,et al.  PEGylated cationic nanoassemblies based on triblock copolymers to combine siRNA therapeutics with anticancer drugs. , 2021, Biomaterials science.

[33]  Jun Wu.  The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application , 2021, Journal of personalized medicine.

[34]  F. Bertucci,et al.  A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery , 2021, ESMO open.

[35]  Jiake Xu,et al.  Current research progress in targeted anti‐angiogenesis therapy for osteosarcoma , 2021, Cell proliferation.

[36]  Bo Xiao,et al.  Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases. , 2021, Advanced drug delivery reviews.

[37]  T. Anirudhan,et al.  Glycyrrhetinic acid conjugated zein capped aminated mesoporous silica nanoparticle-based dual drug delivery system for liver: A pH-dependent triggered release , 2021, Journal of Molecular Liquids.

[38]  Qian Bai,et al.  Advances of smart nano-drug delivery systems in osteosarcoma treatment. , 2021, Journal of materials chemistry. B.

[39]  R. Gorlick,et al.  Advancing therapy for osteosarcoma , 2021, Nature Reviews Clinical Oncology.

[40]  Z. Qian,et al.  Recent progress in targeted delivery vectors based on biomimetic nanoparticles , 2021, Signal Transduction and Targeted Therapy.

[41]  P. Kesharwani,et al.  Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeutics , 2021, Journal of biomaterials science. Polymer edition.

[42]  Xi Zhang,et al.  Tumor acidity-induced charge-reversal liposomal doxorubicin with enhanced cancer cell uptake and anticancer activity , 2021 .

[43]  Michael R Hamblin,et al.  Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy. , 2021, Carbohydrate polymers.

[44]  G. Liang,et al.  Glutathione-Depleting Nanomedicines for Synergistic Cancer Therapy. , 2021, ACS nano.

[45]  Shuibin Lin,et al.  Polymeric micelles amplify tumor oxidative stresses through combining PDT and glutathione depletion for synergistic cancer chemotherapy. , 2021, Chemical engineering journal.

[46]  Jaya Lakkakula,et al.  A comprehensive review on alginate-based delivery systems for the delivery of chemotherapeutic agent: Doxorubicin. , 2021, Carbohydrate polymers.

[47]  Hao Hu,et al.  Co-delivery of chemotherapeutic drugs and cell cycle regulatory agents using nanocarriers for cancer therapy , 2021, Science China Materials.

[48]  Enguo Ju,et al.  Hemin particles-functionalized 3D printed scaffolds for combined photothermal and chemotherapy of osteosarcoma , 2021 .

[49]  N. Gong,et al.  Recent progress in mitochondria-targeting-based nanotechnology for cancer treatment. , 2021, Nanoscale.

[50]  Nageswaran Sivalingam,et al.  A comprehensive review on time-tested anticancer drug doxorubicin. , 2021, Life sciences.

[51]  M. Bilal,et al.  A review of the nanomaterials use for the diagnosis and therapy of salmonella typhi , 2021 .

[52]  Mahmood Barani,et al.  Development of a multifunctional system based on CoFe2O4@polyacrylic acid NPs conjugated to folic acid and loaded with doxorubicin for cancer theranostics , 2021, Nanotechnology.

[53]  Deep Pooja,et al.  Self-assembled and pH-responsive polymeric nanomicelles impart effective delivery of paclitaxel to cancer cells , 2021, RSC advances.

[54]  A. Nomani,et al.  Doxorubicin delivery to breast cancer cells with transferrin-targeted carbon quantum dots: An in vitro and in silico study , 2021 .

[55]  K. Shirai,et al.  Dosimetric Comparison of Radiation Therapy Using Hybrid-VMAT Technique for Stage I Esophageal Cancer , 2021, AntiCancer Research.

[56]  T. Perova,et al.  Electrospun Fibres of Chitosan/PVP for the Effective Chemotherapeutic Drug Delivery of 5-Fluorouracil , 2021, Chemosensors.

[57]  N. López-Bigas,et al.  Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer , 2021, Nature communications.

[58]  A. Arpanaei,et al.  Ultrasound-mediated gene delivery into suspended plant cells using polyethyleneimine-coated mesoporous silica nanoparticles , 2021, Ultrasonics sonochemistry.

[59]  Zhongyi Liu,et al.  Optimized mesoporous silica nanoparticle-based drug delivery system with removable manganese oxide gatekeeper for controlled delivery of doxorubicin. , 2021, Journal of colloid and interface science.

[60]  B. Ghosh,et al.  Polymeric micelles in cancer therapy: State of the art. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[61]  Xianglin Luo,et al.  Using copper sulfide nanoparticles as cross-linkers of tumor microenvironment responsive polymer micelles for cancer synergistic photo-chemotherapy. , 2021, Nanoscale.

[62]  V. Awasthi,et al.  Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors , 2021, Frontiers in Pharmacology.

[63]  Y. Assaraf,et al.  Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance. , 2021, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[64]  J. Massagué,et al.  Targeting metastatic cancer , 2021, Nature Medicine.

[65]  D. Qujeq,et al.  Melatonin and doxorubicin co-delivered via a functionalized graphene-dendrimeric system enhances apoptosis of osteosarcoma cells. , 2020, Materials science & engineering. C, Materials for biological applications.

[66]  Jinmei He,et al.  Chitosan based pH-responsive polymeric prodrug vector for enhanced tumor targeted co-delivery of doxorubicin and siRNA. , 2020, Carbohydrate polymers.

[67]  Jun Huang,et al.  pH-Sensitive nanogels for drug delivery in cancer therapy. , 2020, Biomaterials science.

[68]  T. Gong,et al.  Chondroitin-modified lipid nanoparticles target the Golgi to degrade extracellular matrix for liver cancer management. , 2020, Carbohydrate polymers.

[69]  Yueqing Gu,et al.  Diversified strategies based on nanoscale metal-organic frameworks for cancer therapy: The leap from monofunctional to versatile , 2020 .

[70]  P. K. Sahoo,et al.  Recent advances and prospects in Gemcitabine drug delivery systems. , 2020, International journal of pharmaceutics.

[71]  D. Yadav,et al.  PEGYLATION: an important approach for novel drug delivery system , 2020, Journal of biomaterials science. Polymer edition.

[72]  A. Silva,et al.  Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology , 2020, Molecules.

[73]  D. Vigetti,et al.  Cell Energy Metabolism and Hyaluronan Synthesis , 2020, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[74]  Michael R Hamblin,et al.  Nanovehicles for co-delivery of anticancer agents. , 2020, Drug discovery today.

[75]  D. Merlin,et al.  Lipid-Based Drug Delivery Nanoplatforms for Colorectal Cancer Therapy , 2020, Nanomaterials.

[76]  M. Maaza,et al.  Floral extracts-mediated green synthesis of NiO nanoparticles and their diverse pharmacological evaluations , 2020, Journal of biomolecular structure & dynamics.

[77]  S. Mitragotri,et al.  Targeting Strategies for Tissue-Specific Drug Delivery , 2020, Cell.

[78]  Anping Li,et al.  The role of cancer-derived microRNAs in cancer immune escape , 2020, Journal of Hematology & Oncology.

[79]  U. Banerji,et al.  Exploiting the folate receptor α in oncology , 2020, Nature Reviews Clinical Oncology.

[80]  R. Ivkov,et al.  Nanoparticle interactions with immune cells dominate tumor retention and induce T cell–mediated tumor suppression in models of breast cancer , 2020, Science Advances.

[81]  H. Raissi,et al.  Understanding loading, diffusion and releasing of Doxorubicin and Paclitaxel dual delivery in graphene and graphene oxide carriers as highly efficient drug delivery systems , 2020 .

[82]  R. Tabor,et al.  Bioinspired polynorepinephrine nanoparticles as an efficient vehicle for enhanced drug delivery. , 2020, Journal of materials chemistry. B.

[83]  Zhiyu Zhang,et al.  Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy , 2020, Drug delivery.

[84]  Walaa F. Alsanie,et al.  Predominance of Infection With Blastocystis hominis in Patients With Colorectal Cancer and Its Association With High Mucin Content, Infiltration of Inflammatory Cells and Elevated Serum Tumor Necrosis Factor α , 2020 .

[85]  A. Bishayee,et al.  Medicinal Plants in the Prevention and Treatment of Colon Cancer , 2019, Oxidative medicine and cellular longevity.

[86]  Yongheng Chen,et al.  Nanotechnology in cancer diagnosis: progress, challenges and opportunities , 2019, Journal of Hematology & Oncology.

[87]  Doxorubicin , 2019, Reactions Weekly.

[88]  L. C. Montemiglio,et al.  Structural analysis of the transferrin receptor multifaceted ligand(s) interface. , 2019, Biophysical chemistry.

[89]  Kakarla Raghava Reddy,et al.  Recent developments in functionalized polymer nanoparticles for efficient drug delivery system , 2019, Nano-Structures & Nano-Objects.

[90]  J. Ferlay,et al.  Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study. , 2019, The Lancet. Oncology.

[91]  Xia-Wei Wei,et al.  Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases. , 2019, Biochimica et biophysica acta. Reviews on cancer.

[92]  Z. A. Raza,et al.  Current applications of electrospun polymeric nanofibers in cancer therapy. , 2019, Materials science & engineering. C, Materials for biological applications.

[93]  Marjan Ghorbani,et al.  A novel smart PEGylated gelatin nanoparticle for co-delivery of doxorubicin and betanin: A strategy for enhancing the therapeutic efficacy of chemotherapy. , 2019, Materials science & engineering. C, Materials for biological applications.

[94]  S. Ku,et al.  Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells , 2019, Pharmaceutics.

[95]  Eric P. Winer,et al.  Breast Cancer Treatment: A Review , 2019, JAMA.

[96]  A. Dubrovska,et al.  Graphene Oxide Functional Nanohybrids with Magnetic Nanoparticles for Improved Vectorization of Doxorubicin to Neuroblastoma Cells , 2018, Pharmaceutics.

[97]  Marjan Ghorbani,et al.  A novel multi stimuli-responsive PEGylated hybrid gold/nanogels for co-delivery of doxorubicin and 6‑mercaptopurine. , 2018, Materials science & engineering. C, Materials for biological applications.

[98]  Muhammed Erkan Karabekmez,et al.  Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cells , 2018, Scientific Reports.

[99]  Ahad Mokhtarzadeh,et al.  Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment , 2018, Artificial cells, nanomedicine, and biotechnology.

[100]  R. Saha,et al.  Nanostructured lipid carriers for site-specific drug delivery. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[101]  Zabta Khan Shinwari,et al.  Sageretia thea (Osbeck.) modulated biosynthesis of NiO nanoparticles and their in vitro pharmacognostic, antioxidant and cytotoxic potential , 2018, Artificial cells, nanomedicine, and biotechnology.

[102]  T. Wang,et al.  Tumor angiogenesis and anti-angiogenic gene therapy for cancer , 2018, Oncology letters.

[103]  B. van Calster,et al.  Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. , 2018, The Lancet. Oncology.

[104]  Xuesi Chen,et al.  Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma , 2018, Advanced science.

[105]  N. Zhao,et al.  Advances in delivery systems for doxorubicin. , 2018, Journal of nanomedicine & nanotechnology.

[106]  Chih-Yang Huang,et al.  A review on the effects of current chemotherapy drugs and natural agents in treating non–small cell lung cancer , 2017, BioMedicine.

[107]  Jingqi Wang,et al.  A systematic analysis of FDA-approved anticancer drugs , 2017, BMC Systems Biology.

[108]  S. Davaran,et al.  Liposome-based drug co-delivery systems in cancer cells. , 2017, Materials science & engineering. C, Materials for biological applications.

[109]  X. Wu,et al.  Polymer-lipid hybrid nanoparticles synchronize pharmacokinetics of co-encapsulated doxorubicin-mitomycin C and enable their spatiotemporal co-delivery and local bioavailability in breast tumor. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[110]  Lingbing Li,et al.  pH-sensitive polymeric micelles formed by doxorubicin conjugated prodrugs for co-delivery of doxorubicin and paclitaxel. , 2016, Carbohydrate polymers.

[111]  D. Merlin,et al.  Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy. , 2015, Nanoscale.

[112]  Shige Wang,et al.  Hollow mesoporous organosilica nanoparticles: a generic intelligent framework-hybridization approach for biomedicine. , 2014, Journal of the American Chemical Society.

[113]  Hong Yuan,et al.  Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin , 2013, International journal of nanomedicine.

[114]  R. Pazo-Cid,et al.  Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review , 2013, Journal of drug delivery.

[115]  J. Long,et al.  Introduction to metal-organic frameworks. , 2012, Chemical reviews.

[116]  Yi Jin,et al.  Polymeric nanoparticles of cholesterol‐modified glycol chitosan for doxorubicin delivery: preparation and in‐vitro and in‐vivo characterization , 2009, The Journal of pharmacy and pharmacology.

[117]  F. Arcamone,et al.  Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesius , 1969, Biotechnology and bioengineering.